Results 221 to 230 of about 14,850 (297)

薬剤薬理学 [PDF]

, 1984
小泉 保, 掛見 正郎, 木村 正康, 木村 郁子, 片山 和憲, 遠藤 真樹子, 鈴木 潤   +6 more
core   +2 more sources

Persistently increased CaMKIIδ autophosphorylation mediates pathologic SR Ca loss in a murine model of Doxorubicin-induced cardiomyopathy. [PDF]

J Mol Cell Cardiol Plus
Feder AL, Tarnowski D, Pfützenreuter AM, Baier MJ, Mustroph J, Nanadikar MS, Katschinski DM, Maier LS, Sag CM.   +8 more
europepmc   +1 more source

Neuroleptic Malignant Syndrome in an Institutionalized Geriatric Patient Following Antipsychotic Switch to Quetiapine: A Fatal Outcome. [PDF]

Cureus
Fernandez Eng IL, García Cruz A, Blanco Espinosa E, Fernandez S, Perez Santiago M.   +4 more
europepmc   +1 more source

A CRISPR activation screen reveals a cilia disassembly pathway mutated in focal cortical dysplasia. [PDF]

Sci Adv
Elliott SD, Ready PJ, Wrinn CM, Ma Q, Edward M, Niescier RF, Escobar I, Sun J, Ganga AK, McAtee CK, Atiş İS, Koleske AJ, Bordey A, Breslow DK.   +13 more
europepmc   +1 more source

Failing hearts are more vulnerable to dobutamine and caffeine-induced ventricular arrhythmias: Ameliorated with dantrolene treatment. [PDF]

Heart Rhythm O2
Greco LV, Charest A, Li Y, Udo-Bellner L, Ojamaa K, Gerdes AM, Zhang Y.   +6 more
europepmc   +1 more source

Trends in antidote use in France from 2015 to 2021: a nationwide poison centers study. [PDF]

Sci Rep
Pouget AM, Blanc-Brisset I, Guillotin S, Gerussi M, Pélissier F, French PCC Research Group, Vodovar D, Delcourt N.   +7 more
europepmc   +1 more source

It will happen once in a lifetime: learning from the SIAARTI survey on malignant hyperthermia clinical practices. [PDF]

J Anesth Analg Crit Care
Sbaraglia F.
europepmc   +1 more source

Letter: Hallucinations associated with dantrolene sodium therapy.

, 1975
Leslie G. Andrews, A. S. Muzumdar, A. Pinkerton   +2 more
openalex   +1 more source

Symptomatic and Prophylactic Dantrolene Treatment in a Case of RYR1 -Related Congenital Myopathy. [PDF]

Ann Indian Acad Neurol
Şenol HB, Polat AI, Aydın A, Hız AS, Yiş U.   +4 more
europepmc   +1 more source